245 related articles for article (PubMed ID: 24225206)
1. Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials.
Budach W; Kammers K; Boelke E; Matuschek C
Radiat Oncol; 2013 Nov; 8():267. PubMed ID: 24225206
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update.
Budach W; Bölke E; Kammers K; Gerber PA; Nestle-Krämling C; Matuschek C
Radiat Oncol; 2015 Dec; 10():258. PubMed ID: 26691175
[TBL] [Abstract][Full Text] [Related]
3. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
Poortmans PM; Weltens C; Fortpied C; Kirkove C; Peignaux-Casasnovas K; Budach V; van der Leij F; Vonk E; Weidner N; Rivera S; van Tienhoven G; Fourquet A; Noel G; Valli M; Guckenberger M; Koiter E; Racadot S; Abdah-Bortnyak R; Van Limbergen EF; Engelen A; De Brouwer P; Struikmans H; Bartelink H;
Lancet Oncol; 2020 Dec; 21(12):1602-1610. PubMed ID: 33152277
[TBL] [Abstract][Full Text] [Related]
4. Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysis.
Haussmann J; Budach W; Tamaskovics B; Bölke E; Corradini S; Djiepmo-Njanang FJ; Kammers K; Matuschek C
Radiat Oncol; 2019 Jun; 14(1):102. PubMed ID: 31186015
[TBL] [Abstract][Full Text] [Related]
5. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
6. Internal Mammary Node Radiation in Light of the EORTC 22922 and MA.20 Trials-What Have We Really Learned?
Verma V; Beriwal S
JAMA Oncol; 2016 Aug; 2(8):992-3. PubMed ID: 27244127
[No Abstract] [Full Text] [Related]
7. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
[TBL] [Abstract][Full Text] [Related]
8. Internal mammary nodal irradiation in conservatively-managed breast cancer patients: is there a benefit?
Obedian E; Haffty BG
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):997-1003. PubMed ID: 10421532
[TBL] [Abstract][Full Text] [Related]
9. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
[TBL] [Abstract][Full Text] [Related]
10. Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design.
Borm KJ; Oechsner M; Düsberg M; Buschner G; Weber W; Combs SE; Duma MN
Radiother Oncol; 2020 Jan; 142():195-201. PubMed ID: 31540747
[TBL] [Abstract][Full Text] [Related]
11. Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Gingras I; Holmes E; De Azambuja E; Nguyen DH; Izquierdo M; Anne Zujewski J; Inbar M; Naume B; Tomasello G; Gralow JR; Wolff AC; Harris L; Gnant M; Moreno-Aspitia A; Piccart MJ; Azim HA
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376188
[TBL] [Abstract][Full Text] [Related]
12. [Controversy about internal mammary chain irradiation in breast cancer].
Hennequin C; Fourquet A
Cancer Radiother; 2014 Oct; 18(5-6):351-5. PubMed ID: 25169067
[TBL] [Abstract][Full Text] [Related]
13. POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
Zhao XR; Fang H; Tang Y; Hu ZH; Jing H; Liang L; Yan XN; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Li N; Lu NN; Men K; Hu C; Zhang YH; Li YX; Wang SL
BMC Cancer; 2021 Nov; 21(1):1185. PubMed ID: 34742270
[TBL] [Abstract][Full Text] [Related]
14. The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes.
Jabro G; Wazer DE; Ruthazer R; Lum R; Sklar N; Goldman D; Enegess D; Erban J
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):273-80. PubMed ID: 10760419
[TBL] [Abstract][Full Text] [Related]
15. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer.
Hetelekidis S; Schnitt SJ; Silver B; Manola J; Bornstein BA; Nixon AJ; Recht A; Gelman R; Harris JR; Connolly JL
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):31-4. PubMed ID: 10656369
[TBL] [Abstract][Full Text] [Related]
16. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
[TBL] [Abstract][Full Text] [Related]
17. Predicting loco-regional recurrence risk in T1, T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram.
Wadasadawala T; Kannan S; Gudi S; Rishi A; Budrukkar A; Parmar V; Shet T; Desai S; Gupta S; Badwe R; Sarin R
Indian J Cancer; 2017; 54(1):352-357. PubMed ID: 29199721
[TBL] [Abstract][Full Text] [Related]
18. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.
Qi WX; Cao L; Zheng S; Xu C; Cai R; Xu H; Cai G; Chen J
BMC Cancer; 2022 Dec; 22(1):1356. PubMed ID: 36575421
[TBL] [Abstract][Full Text] [Related]
19. The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial.
Kaidar-Person O; Fortpied C; Hol S; Weltens C; Kirkove C; Budach V; Peignaux-Casasnovas K; van der Leij F; Vonk E; Valli M; Weidner N; Guckenberger M; Koiter E; Fourquet A; Bartelink H; Struikmans H; Poortmans P;
Radiother Oncol; 2022 Jul; 172():99-110. PubMed ID: 35568284
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer: A Meta-Analysis.
Shaikh PM; Mulherkar R; Khasawneh MT; Clump D; Hazard-Jenkins H; Hafez M; Vargo JA
Am J Clin Oncol; 2024 Feb; 47(2):81-87. PubMed ID: 37916961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
